Therapeutic modulation of inflammasome pathways - Chauhan - 2020

Por um escritor misterioso
Last updated 15 junho 2024
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Cells, Free Full-Text
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors, Translational Neurodegeneration
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Frontiers Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Therapeutic modulation of inflammasome pathways. - Abstract - Europe PMC
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Involvement of inflammasomes in tumor microenvironment and tumor therapies, Journal of Hematology & Oncology
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
IJMS, Free Full-Text
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma - McKee - 2020 - Journal of Leukocyte Biology - Wiley Online Library
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors - Kinra - 2022 - Scandinavian Journal of Immunology - Wiley Online Library
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Frontiers Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
The interaction between ferroptosis and inflammatory signaling pathways
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Frontiers Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
Therapeutic modulation of inflammasome pathways - Chauhan - 2020
Frontiers Inflammasome Activation in Myeloid Malignancies—Friend or Foe?

© 2014-2024 rahh.de. All rights reserved.